R. Christodoulopoulos

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

Ryan D. Morin, Lauren C. Chong, C. Greenwood, 2016, Blood.

The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience

G. Batist, A. Robidoux, M. Basik, 2017, Modern Pathology.